Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice

Hepatology

Volumn 56, Issue 1, 2012, Pages 311-321

  Moriya, Kei ^a   Sakai, Keiko ^a   Yan, Michel H ^a   Sakai, Takao ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Orthopaedic and Rheumatologic Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN TYPE 1; FIBRONECTIN; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; LIVER CELL; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DRUG-INDUCED LIVER INJURY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RANDOM ALLOCATION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 84863521937     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25624     Document Type: Article

References (44)

1. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010; 376: 190-201.
2. Pathikonda M, Munoz SJ. Acute liver failure. Ann Hepatol 2010; 9: 7-14.
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-218.
4. Clark RAF. The Molecular and Cellular Biology Of Wound Repair, 2nd ed. New York: Plenum Press; 1996: xxiii.
5. Mosher DF. Fibronectin. San Diego: Academic Press; 1989: xviii.
6. Hynes RO. Fibronectins. New York: Springer-Verlag; 1990: xv.
7. Schwarzbauer JE. Fibronectin: from gene to protein. Curr Opin Cell Biol 1991; 3: 786-791.
8. Gressner OA, Weiskirchen R, Gressner AM. Biomarkers of hepatic fibrosis, fibrogenesis, and genetic pre-disposition pending between fiction and reality. J Cell Mol Med 2007; 11: 1031-1051.
9. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-851.
10. Sakai T, Johnson KJ, Murozono M, Sakai K, Magnuson MA, Wieloch T, et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med 2001; 7: 324-330.
11. Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 2002; 277: 37377-37381.
12. Sottile J, Hocking DC. Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 2002; 13: 3546-3559.
13. Sottile J, Shi F, Rublyevska I, Chiang HY, Lust J, Chandler J. Fibronectin-dependent collagen I deposition modulates the cell response to fibronectin. Am J Physiol Cell Physiol 2007; 293: C1934-C1946.
14. Moriya K, Bae E, Honda K, Sakai K, Sakaguchi T, Tsujimoto I, et al. A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling. Gastroenterology 2011; 140: 1653-1663.
15. Caputi M, Melo CA, Baralle FE. Regulation of fibronectin expression in rat regenerating liver. Nucleic Acids Res 1995; 23: 238-243.
16. Sawada N, Tomomura A, Sattler CA, Sattler GL, Kleinman HK, Pitot HC. Extracellular matrix components influence DNA synthesis of rat hepatocytes in primary culture. Exp Cell Res 1986; 167: 458-470.
17. Tsujimoto I, Moriya K, Sakai K, Dickneite G, Sakai T. Critical role of factor XIII in the initial stages of carbon tetrachloride-induced adult liver remodeling. Am J Pathol 2011; 179: 3011-3019.
18. Hayashi H, Sakai, K, Baba, H, Sakai, T. Thrombospondin-1 is a novel negative regulator of liver regeneration after partial hepatectomy through transforming growth factor-beta1 activation in mice. Hepatology 2011. doi: 10.1002/hep.24800.
19. Maeda T, Sakabe T, Sunaga A, Sakai K, Rivera AL, Keene DR, et al. Conversion of mechanical force into TGF-beta-mediated biochemical signals. Curr Biol 2011; 21: 933-941.
20. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv Cancer Res 1999; 76: 1-20.
21. Globus RK, Doty SB, Lull JC, Holmuhamedov E, Humphries MJ, Damsky CH. Fibronectin is a survival factor for differentiated osteoblasts. J Cell Sci 1998; 111: 1385-1393.
22. Almeida EA, Ilic D, Han Q, Hauck CR, Jin F, Kawakatsu H, et al. Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. J Cell Biol 2000; 149: 741-754.
23. Gilmore AP. Anoikis. Cell Death Differ 2005; 12( Suppl 2): 1473-1477.
24. Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev 2010; 90: 1165-1194.
25. Tzung SP, Fausto N, Hockenbery DM. Expression of Bcl-2 family during liver regeneration and identification of Bcl-x as a delayed early response gene. Am J Pathol 1997; 150: 1985-1995.
26. Wu J, Norton PA. Animal models of liver fibrosis. Scand J Gastroenterol 1996; 31: 1137-1143.
27. Rojkind M, Greenwel P. Animal models of liver fibrosis. Adv Vet Sci Comp Med 1993; 37: 333-355.
28. Schmidt M, Gerlach F, Avivi A, Laufs T, Wystub S, Simpson JC, et al. Cytoglobin is a respiratory protein in connective tissue and neurons, which is up-regulated by hypoxia. J Biol Chem 2004; 279: 8063-8069.
29. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-847.
30. Balabaud C, Bioulac-Sage P, Desmouliere A. The role of hepatic stellate cells in liver regeneration. J Hepatol 2004; 40: 1023-1026.
31. Maher JJ. Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest 1993; 91: 2244-2252.
32. Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 2007; 315: 1853-1856.
33. Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration, and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-848.
34. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 588-610.
35. Reddig PJ, Juliano RL. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 2005; 24: 425-439.
36. Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 2003; 33: 105-136.
37. Qiu Z, Kwon AH, Tsuji K, Kamiyama Y, Okumura T, Hirao Y. Fibronectin prevents D-galactosamine/lipopolysaccharide-induced lethal hepatic failure in mice. Shock 2006; 25: 80-87.
38. Tomasini-Johansson B, Mosher DF. Plasma fibronectin concentration in inbred mouse strains. Thromb Haemost 2009; 102: 1278-1280.
39. Lorand L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 291-311.
40. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-156.
41. Ilic D, Almeida EA, Schlaepfer DD, Dazin P, Aizawa S, Damsky CH. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J Cell Biol 1998; 143: 547-560.
42. Takehara T, Tatsumi T, Suzuki T, Rucker EB3rd, Hennighausen L, Jinushi M, et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 2004; 127: 1189-1197.
43. Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ 2006; 13: 1351-1359.
44. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, et al. Cell survival, cell death, and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007; 10: 13-29.